Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Colin James Walsh Insider Profile
4 Followers
Colin James Walsh, Director at Fusion Antibodies Plc, holds 2.56M shares in Fusion Antibodies Plc (Ticker: GB:FAB).
Colin James Walsh has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Colin James Walsh's holdings
Insider Roles
Director
Roles that Colin James Walsh holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:May 19, 2023 - May 19, 2024
Return:-56.10%
The most profitable trade made by Colin James Walsh
Colin James Walsh's Trading History
List of latest transactions for each holding click on a transaction to see Colin James Walsh's performance on stock
You May Also Like
Colin James Walsh insider profile FAQ
What is the percentage of profitable transactions made by Colin James Walsh?
The percentage of profitable transactions made by Colin James Walsh is ―.
What is the average return per transaction made by Colin James Walsh?
The average return per transaction made by Colin James Walsh is ―.
What stocks does Colin James Walsh hold?
Colin James Walsh holds: GB:FAB stocks.
What was Colin James Walsh’s latest transaction?
Colin James Walsh latest transaction was an Uninformative Buy of 22.50K.
What was Colin James Walsh's most profitable transaction?
Colin James Walsh’s most profitable transaction was an Informative Buy of GB:FAB stock on May 19, 2023. The return on the trade was -56.10%.
What is Colin James Walsh's role in Fusion Antibodies Plc?
Colin James Walsh's role in Fusion Antibodies Plc is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.